Saranac Partners »

Novo Nordisk A/S shares owned by Saranac Partners

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Saranac Partners from 13F filings

Historical chart of Saranac Partners investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Saranac Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Saranac Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $532k 11k 47.94

More positions owned by Saranac Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Bank of America Corporation (BAC)
Abbvie (ABBV)
Applied Materials (AMAT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ametek (AME)
TJX Companies (TJX)
UnitedHealth (UNH)
Trane Technologies SHS (TT)

View all positions for Saranac Partners

Top funds holding Novo Nordisk A/S

Susquehanna International
Dodge & Cox
Citadel Advisors
Loomis, Sayles and
Franklin Resources
Goldman Sachs Group
Jane Street
Bank of America Corporation
T. Rowe Price Associates
Morgan Stanley
Capital Research and Management Company - Division 3
Folketrygdfondet
D. E. Shaw & Co
Fisher Investments
Arrowstreet Capital, Limited Partnership

View all funds holding Novo Nordisk A/S